Read + Share
Baker S, Lechner L, Liu M, Chang JS, et al. Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer
Treated With SABR in the Phase 2 SABR-5 Trial. Int J Radiat Oncol Biol Phys 2024;118:1497-1506.
PMID: 38220069
|
 |
|
Baker S, Lechner L, Liu M, Chang JS, et al. Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer
Treated With SABR in the Phase 2 SABR-5 Trial. Int J Radiat Oncol Biol Phys 2024;118:1497-1506.
PMID: 38220069
|
|
|
|